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Abstract
In insects, precisely timed periodic pulses of the molting hormone ecdysone control major developmental transitions such
as molts and metamorphosis. The synthesis and release of ecdysone, a steroid hormone, is itself controlled by PTTH
(prothoracicotopic hormone). PTTH transcript levels oscillate with an 8 h rhythm, but its significance regarding the timing of
ecdysone pulses is unclear. PTTH acts on its target tissue, the prothoracic gland (PG), by activating the Ras/Raf/ERK pathway
through its receptor Torso, however direct targets of this pathway have yet to be identified. Here, we demonstrate that
Drosophila Hormone Receptor 4 (DHR4), a nuclear receptor, is a key target of the PTTH pathway and establishes temporal
boundaries by terminating ecdysone pulses. Specifically, we show that DHR4 oscillates between the nucleus and cytoplasm
of PG cells, and that the protein is absent from PG nuclei at developmental times when low titer ecdysone pulses occur. This
oscillatory behavior is blocked when PTTH or torso function is abolished, resulting in nuclear accumulation of DHR4, while
hyperactivating the PTTH pathway results in cytoplasmic retention of the protein. Increasing DHR4 levels in the PG can
delay or arrest development. In contrast, reducing DHR4 function in the PG triggers accelerated development, which is
caused by precocious ecdysone signaling due to a failure to repress ecdysone pulses. Finally, we show that DHR4 negatively
regulates the expression of a hitherto uncharacterized cytochrome P450 gene, Cyp6t3. Disruption of Cyp6t3 function causes
low ecdysteroid titers and results in heterochronic phenotypes and molting defects, indicating a novel role in the ecdysone
biosynthesis pathway. We propose a model whereby nuclear DHR4 controls the duration of ecdysone pulses by negatively
regulating ecdysone biosynthesis through repression of Cyp6t3, and that this repressive function is temporarily overturned
via the PTTH pathway by removing DHR4 from the nuclear compartment.
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Introduction
The development of higher organisms is fundamentally
dependent on the precise progression of specific gene programs,
and even minor differences in the timing of these events can be
fatal [1,2]. The regulation of simultaneous developmental
programs generally relies on systemic signals—typically hor-
mones—that coordinate these activities. In most, if not all
multicellular organisms, steroid hormones function as precisely
timed cues that control diverse gene programs to advance
development or synchronize physiological changes. In humans,
for example, the onset of puberty—while ultimately under
neuroendocrine control—is governed by the action of steroid
hormones that coordinate the developmental and behavioral
changes associated with sexual maturation [3].
Typically, the release of steroid hormones from their respective
glands is temporally controlled, resulting in systemic pulses of
defined duration [4]. This raises the interesting question as to how
onset, size, and duration of hormone pulses are regulated, since all
these variables will affect target tissue responses. The insect
molting hormone ecdysone represents an excellent model to
address these questions, allowing us to study the dynamic effects of
a steroid hormone in the context of a developing organism. In
Drosophila, major and minor ecdysone pulses (corresponding to
high and low hormone titers, respectively) occur throughout
development [5]. The major pulses of ecdysone control the molts,
the onset of metamorphosis, and the differentiation of adult tissues,
while the minor pulses are linked to changes in physiology, such as
the termination of feeding behavior. During larval development,
ecdysone is mainly synthesized in the PG, and following its release
into the hemolymph the hormone is converted to its biologically
active form, 20-Hydroxyecdysone (20E), in peripheral tissues [6].
In Drosophila melanogaster, at least three minor ecdysone pulses
occur in third instar (L3) larvae. These pulses are required for
important changes in physiology and behavior, including the
commitment of a larva to a pupal fate (critical weight checkpoint),
the induction of the Sgs (‘‘glue’’) genes that serve to attach the pupa
to a solid substrate, and the switch from feeding to wandering
behavior [7–11]. Critical weight is a physiological checkpoint that
determines whether the larva has acquired sufficient resources to
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puparium formation. Once critical weight is attained, the larva will
pupariate within normal time, regardless of whether nutrients are
scarce or abundant [12–14].
The accurate timing of the major and minor ecdysone pulses
suggests that the molecular mechanisms by which the hormone is
synthesized, released, and degraded are tightly regulated. The past
decade has provided considerable insight into the biosynthetic
pathway that converts dietary cholesterol to 20E. Six genes linked
to the Halloween mutations encode two different enzyme classes
that act in the ecdysone/20E biosynthetic pathway, the cyto-
chrome P450 monooxygenases (disembodied, phantom, shadow, shade,
and spook) [15–20], and a short-chain dehydrogenase/reductase
(shroud) [21]. Two non-Halloween genes have been shown to also
play a role in ecdysone synthesis, neverland, which encodes a Rieske
electron oxygenase [22,23] and spookier, a paralog of spook [24].
The first and final biochemical steps of ecdysteroid biosynthesis
are reasonably well understood, however relatively little is known
about the enzymes that catalyze the intermediate steps, namely the
conversion from 7-dehydrocholesterol to 5b-ketodiol. This suc-
cession of uncharacterized reactions is generally referred to as the
‘‘Black Box’’ and is believed to harbor the rate-limiting step for the
production of ecdysone [25]. Recent work suggests that shroud and
spookier (spook in Manduca and Bombyx) act in the ‘‘Black Box’’
[21,24], however it is still unknown which enzymatic steps are
catalyzed by these enzymes, and whether other enzymes also act in
the Black Box.
Some Halloween genes are transcriptionally upregulated when
ecdysone levels are high; in Bombyx and Manduca, for example, the
expression levels of phantom (phm) mRNA correlate well with the
two ecdysone peaks preceding pupation [17,20,26]. In Drosophila,
phm, shadow (sad), and shade (shd) are induced roughly 12 h before
puparium formation, concurrent with the major pulse of ecdysone
that triggers this event. However, transcript and protein levels of
these three Halloween genes appear to be relatively constant
during the first 36 h of the L3 [27], suggesting that the three low-
titer 20E pulses are not simply a consequence of modulating gene
expression of the Halloween genes. Therefore, it is unclear
whether the generation of minor ecdysone pulses involves
transcriptional control of any of the known or hitherto unidentified
Halloween genes or whether regulation at the transcriptional level
plays a role at all. In this study, we show that DHR4 appears to act
as a transcriptional repressor of Cyp6t3, a cytochrome P450 gene
with a previously unknown role in ecdysteroid biosynthetic
pathway.
The neuropeptide PTTH is believed to control the timing of all
major ecdysone peaks during larval and pupal development [28],
however it is unclear whether low-titer ecdysone pulses are also
controlled in this manner. Seminal studies conducted in Bombyx
resulted in the identification of PTTH as a brain-derived
neuropeptide, which triggers the production of ecdysone in the
PG [29], however the gene encoding PTTH was only recently
identified in Drosophila [30]. PTTH is sufficient to upregulate some
ecdysteroidogenic genes in cultured Bombyx PGs [31,32], and
ablation of PTTH-producing neurons in Drosophila results in
reduced expression of Halloween genes [30]. Surprisingly, ablating
PTTH-producing neurons did not abrogate molting or metamor-
phosis, but instead caused substantial developmental delays with
long larval feeding periods that resulted in large animals. This
suggests that PTTH acts as a timer that coordinates key
developmental transitions and final body size of the developing
Drosophila larva, but that it is not essential for molting and
metamorphosis per se. Interestingly, the same report demonstrated
that PTTH mRNA displays an unusual cyclic pattern during the
L3, with transcript levels peaking every 8 h. Whether this
unexpected transcriptional profile translates into corresponding
changes of PTTH peptide levels is unknown, but it is plausible that
these PTTH mRNA oscillations are causally linked to the minor
ecdysone pulses that occur during the L3 in Drosophila.
A recent report showed that Drosophila PTTH binds to the
Receptor Tyrosine Kinase encoded by the torso gene [33]. Torso
expression is highly specific to the PG and disruption of torso
function via tissue-specific RNA interference (RNAi) phenocopies
the PTTH ablation experiments. Importantly, the authors also
demonstrate that PTTH stimulates ecdysone production through
ERK/MAPK, Ras, and Raf, and that loss-of-function of these
pathway components (ERK, Ras85D, and dRaf) via RNAi yield
large, delayed animals comparable to those seen in the PTTH
ablation or torso RNAi experiments. Conversely, when a
constitutively active form of Ras (Ras
V12) [34] was expressed
specifically in the PG, larval development was accelerated,
resulting in small, precocious pupae.
We previously described a strong hypomorphic mutation in the
DHR4 gene (DHR4
1) that results in prepupal lethality and defects
in developmental timing [35]. DHR4
1 mutants spend less time
feeding than controls and exhibit precocious wandering behavior
as well as premature pupariation, ultimately resulting in smaller
body sizes. DHR4 encodes an orphan nuclear receptor most
similar to the vertebrate receptor Germ Cell Nuclear Factor
[36,37]. In our original report [35], we found that DHR4 is highly
abundant in the cytoplasm of PG cells in mid and late L3 larvae,
with little or no detectable protein in the nucleus. We found no
DHR4 expression in the two neighboring endocrine tissues of the
ring gland (RG), the corpus allatum, or the corpora cardiaca. We show
here that nuclear import of DHR4 is developmentally regulated,
and that the protein exhibits a precise nucleocytoplasmic
oscillatory pattern in L3 larvae. We also provide evidence that
this oscillatory behavior is controlled by PTTH signaling and that
DHR4 counteracts the stimulating activity of this neuropeptide by
repressing ecdysone pulses. Furthermore, we demonstrate that the
accelerated switch from feeding to wandering behavior is
consistent with a precocious rise in ecdysone concentrations due
Author Summary
Steroid hormones play fundamental roles in development
and disease. They are often released as pulses, thereby
orchestrating multiple physiological and developmental
changes throughout the body. Hormone pulses must be
regulated in a way so that they have a defined beginning,
peak, and end. In Drosophila, pulses of the steroid
hormone ecdysone govern all major developmental
transitions, such as the molts or the transformation of a
larva to a pupa. While we have a relatively good
understanding of how an ecdysone pulse is initiated, little
is known about how hormone production is turned off. In
this study, we identify a critical regulator of this process,
the nuclear receptor DHR4. When we interfere with the
function of DHR4 specifically in the ecdysone-producing
gland, we find that larvae develop much faster than
normal, and that this is caused by the inability to turn off
ecdysone production. We show that DHR4 oscillates
between cytoplasm and nucleus of ecdysone-producing
cells under the control of a neuropeptide that regulates
ecdysone production. When the neuropeptide pathway is
inactive, DHR4 enters the nucleus and represses another
gene, Cyp6t3, for which we show a novel role in the
production of ecdysone.
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knocked down. Based on RG-specific microarrays, we show that
Cyp6t3 is a cytochrome P450 gene specifically expressed in the RG,
and that the gene is normally repressed by DHR4. Further, we
demonstrate that Cyp6t3 plays a key role in ecdysone biosynthesis
and that disruption of its function results in low ecdysone titers as
well as developmental timing and molting phenotypes. These
phenotypes can be rescued by providing an ecdysteroid precursor,
5b-ketodiol, as well as with feeding 20E or ecdysone. We propose a
model by which DHR4 inhibits ecdysone synthesis through the
regulation of cytochrome P450 genes, and whereby PTTH activity
triggers the translocation of DHR4 from the nucleus to the
cytoplasm to temporarily relieve this inhibition, thus allowing for
ecdysone pulses to occur.
Results
DHR4
1 Mutants Display a Range of Growth Defects
In a previous report, we demonstrated that DHR4
1 larvae
engage in wandering behavior much earlier than controls, which
in turn results in precocious pupariation [35]. We also showed that
DHR4
1 mutants die as prepupae that are smaller than controls
(Figure 1A). Here, we describe an additional growth phenotype—
the dwarf larva—that affects ,5% of the mutant population
(Figure 1B). These remarkably small L3 larvae do not feed, are
unable to pupariate, and eventually perish as almost transparent
larvae due to depleted fat stores (Figure 1B). This extreme growth
defect is likely caused by a very early onset of wandering behavior,
which is in line with the observation that we consistently observe a
small percentage of wandering second instar (L2) larvae in
populations of DHR4
1 mutants (unpublished data).
In our previous report we also showed that DHR4
1 mutants
commit earlier to puparium formation than controls. Specifically,
when young L3 larvae are transferred to cycloheximide-containing
media (which inhibits growth by blocking protein synthesis),
DHR4
1 mutants are able to pupariate under these conditions,
while controls fail to do so, suggesting that the critical weight
checkpoint occurs earlier in DHR4
1 mutants than controls. This in
turn results in early wandering behavior and the ability to
pupariate since feeding/cycloheximide uptake has stopped.
These two observations raise the possibility that at least some
ecdysone pulses occur precociously in DHR4
1 mutants, thus
triggering early critical weight assessment, early onset of
wandering behavior, and precocious pupariation. DHR4 is
expressed in the PG throughout larval stages and in the fat body
prior to molts (Figure S1), raising the question of which of the two
tissues is critical for DHR4-dependent regulation of development
timing.
Developmental Timing Phenotypes Are Linked to DHR4
Expression in the PG
To examine whether it is the expression of DHR4 in the fat
body or the PG that is linked to the defects in the timing of
wandering behavior and puparium formation, we used the Gal4
system to induce tissue-specific RNAi against DHR4 in either of
these tissues. We found that single copies of the Gal4 driver and
responder transgenes were insufficient to elicit reliable phenotypes.
However, when we used lines homozygous for both the driver
(RG: P0206-Gal4, fat body: Cg-Gal4) and the responder (UAS-
DHR4-RNAi), we found that DHR4 RNAi in the ring gland
triggers phenotypes consistent with early wandering, while fat
body-specific RNAi resulted in prepupal lethality in ,10% of the
population (compared to 0% in controls, unpublished data). In
particular, P0206-Gal4 driven DHR4-RNAi in the ring gland
resulted in early pupariation (Figure 1C) and small precocious
prepupae (Figure 1A), while fat body-specific interference of DHR4
expression yielded phenotypes consistent with a defect in the
ecdysone hierarchy, namely prepupal lethality, the failure to evert
anterior spiracles (unpublished data), incomplete or absent head
eversion, and incorrect location of the gas bubble (Figure 1A).
Importantly, we did not observe any timing defects in Cg.DHR4-
RNAi animals, since we found normally sized pupae that
pupariate with similar timing as controls (Figure 1C). This suggests
that DHR4 expression in the fat body is important for prepupal
development, while it functions in the PG to control the timing of
wandering behavior and puparium formation. The phenotypes
observed with fat body and ring gland-specific DHR4 RNAi lines
recapitulate the phenotypes we observed for the DHR4
1 mutation,
suggesting that DHR4 function is most critical in these two tissues.
Precocious Wandering Behavior Is Linked to DHR4
Expression in Early L3 Larvae
Since critical weight is determined in early L3 larvae, we tested
whether DHR4 function is required during this time to ensure
appropriate timing of wandering behavior. Specifically, we used a
heat-inducible RNAi line (hsDHR4-RNAi) to activate DHR4 RNAi
either 4 h prior to or 4 h after the L2/L3 molt. To examine if
either of these heat treatments affected the timing of wandering
behavior, we determined the percentage of clear-gut larvae at
different time points during the L3 stage. Gut clearing occurs in
wandering L3 larvae, typically 30–36 h after the molt and is
completed around 4–6 h prior to puparium formation. Although
we induced DHR4 RNAi just 8 h apart, we only observe
precocious wandering behavior when the heat treatment is applied
in the late L2, but not in the early L3 (Figure 1D,E). In addition,
we found a small percentage of dwarf larvae when RNAi was
induced in late L2 larvae, while no dwarf larvae were found with
the later heat shock (unpublished data). These data suggest that
DHR4 function around the L2/L3 molt is necessary for the correct
timing of wandering behavior, which corresponds to the time
window when critical weight is determined [38].
DHR4 RNAi Triggers Premature Ecdysone Signaling in L3
Larvae
To test whether early wandering in P0206.DHR4-RNAi larvae
(Figure 1C) is caused by precocious ecdysone signaling, we
examined the expression levels of the glue gene Sgs-4 via
quantitative real-time PCR (qPCR). Sgs-4 represents one of the
first identified ecdysone-inducible genes in Drosophila [39,40].
Roughly 24 h after the molt to the L3 (,96 h after egg
deposition), Sgs-4 is induced in salivary glands by a low titer
ecdysone pulse [10,11], after which the gene maintains high
expression levels until it is abruptly turned off at pupariation. At
24 h after the molt, we observed feeding and wandering larvae in
P0206.DHR4-RNAi populations, while controls show no sign of
wandering behavior. Sgs-4 expression was drastically higher in the
16 h and 24 h RNAi populations relative to controls, and ,2-fold
higher when one compares the wandering with the feeding larvae
in the RNAi group at 24 h (Figure 2A). This indicates that the
wandering cohort has received the 20E pulse that induces Sgs-4
earlier than the feeding cohort. Even at 16 h after the molt, when
all P0206.DHR4-RNAi larvae are still feeding, we observe much
higher expression levels of Sgs-4 compared to controls, suggesting
that the corresponding 20E pulse has occurred already before this
time point, thereby preceding the wild type 20E peak (,20 h after
the molt) by at least 4 h.
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L2 would trigger precocious Sgs-4 induction, since this treatment
triggers premature wandering behavior (Figure 1D). In contrast to
PG-specific DHR4-RNAi, we did not observe induction at 16 h
after the L2/L3 molt, however at the 20 h mark we found that
RNAi larvae had ,3-fold higher Sgs-4 mRNA levels than controls
(Figure 2B). However, when we examined Sgs-4 levels at 24 and
28 h after the molt, we found higher expression of the gene in
controls, suggesting that Sgs-4 is induced precociously, but
submaximally in hsDHR4-RNAi animals. Finally, when heat
shocked in early L3, we do not observe differences in Sgs-4
expression between hsDHR4-RNAi and wild type larvae (Figure
S2), consistent with our observation that only a heat treatment in
late L2 triggers early wandering behavior.
To complement these findings, we analyzed the expression
profiles of two isoforms of the E74 gene, which are both ecdysone-
regulated [41,42]. This approach has been used previously [43]
and is based on the idea that the A and B isoforms of the E74 gene
Figure 1. Disruption of DHR4 ring gland function affects developmental timing. (A) Pupal and prepupal phenotypes include size defects
and malformations. From left to right: P427 parental control line for DHR4
1 mutants, DHR4
1, P0206-Gal4 (x2), P0206.DHR4-RNAi (x2) prepupae of
various sizes, Cg-Gal4 (x2) pupa, Cg.DHR4-RNAi (x2). (B) Dwarf larvae. P427 L3 and L2 are controls. A severe growth defect is observed in populations
of DHR4
1 mutants and phm22.Ras
V12 larvae. The two insets show the morphology of mouth hooks and anterior spiracles of a DHR4
1 L3 dwarf larva at
high magnification. (C) Expression of DHR4-RNAi in the RG causes premature pupariation. Percentages of embryos (staged within a 2-h interval) that
reached pupariation, hours are after egg deposition. Unpaired Student’s t tests between P0206.DHR4-RNAi (x2) (red, N=386) and P0206-Gal4 (x2)
(blue, N=143) for time points 104 to 118 are all p,0.0001 (not indicated in the graph). Cg-Gal4 (x2) (black, N=150) and Cg.DHR4-RNAi (x2) (green,
N=251) examine whether timing differences exist when DHR4-RNAi is fat body-specific. (D, E) Time course shows percentage of clear gut larvae as a
means to measure wandering behavior. Red: DHR4-RNAi (N=122, 133 in D and E). Black: w
1118 controls (N=157, 115 in D and E). Larvae were heat
shocked in late L2 (D) or early L3 (E). p values (* p,0.05, ** p,0.01) are based on Student’s t test and compare hsDHR4 and w
1118 at the same time
point. (C–E) Error bars reflect standard deviation from three to six replicates.
doi:10.1371/journal.pbio.1001160.g001
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PLoS Biology | www.plosbiology.org 4 September 2011 | Volume 9 | Issue 9 | e1001160Figure 2. DHR4-RNAi affects the timing of ecdysone-mediated responses. (A, B) qPCR of Sgs4 transcript levels in P0206.DHR4-RNAi (p4i) (A)
and hsDHR4-RNAi (hs4i) (B) animals, hours are relative to the L2/L3 molt, and fold changes are relative to the control of 4-h (A) or 16-h (B) time points.
Controls are shown in black. Error bars represent 95% confidence intervals, and p values were calculated with the unpaired Student’s t test. (C)
Ecdysteroid measurements during the first 24 h of the third instar. Larvae homozygous either for P0206.DHR4-RNAi (red) or P0206 (blue) were
compared. At least three samples were tested per time point, and each sample was tested in triplicate. Error bars represent standard error and p
values represent results from an unpaired Student’s t test. (D–F) Percent of larvae reaching indicated stage. 1, L1; 2, L2; 3, L3; P, pupae; A, adults. A
starter population of 100 L1 larvae was used for all conditions, each tested in triplicate. phmN1, P0206, Cg: Gal4 transgenes driving expression in the
PG, ring gland and fat body, respectively. 20E: 20-Hydroxyecdysone supplemented in the medium. (D–F) Error bars represent standard deviation. (G)
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ecdysone titer is high, E74A is induced and E74B is repressed, but
when ecdysone titers drop to intermediate concentrations, E74A is
turned off, while E74B mRNA levels rise. Therefore, by measuring
both isoforms using qPCR, we can infer whether ecdysone
concentrations have fallen or risen. When hsDHR4-RNAi animals
are heat shocked as late L2, we find that E74A levels start to rise at
24 h after the molt and remain roughly 2-fold higher than controls
at the 24, 28, 32, and 36 h time points, while E74B levels show a
corresponding drop at 28–36 h (Figure S3, left panels). These
findings suggest a preceding rise in ecdysone concentrations,
consistent with the precocious induction of Sgs-4 discussed above.
When animals received a heat shock 4 h after the L2/L3 molt, we
observed no significant differences in E74A and E74B transcript
levels between hsDHR4-RNAi animals and controls (Figure S3,
right panels), agreeing with our finding that a later induction of
RNAi fails to trigger precocious wandering behavior (Figure 1E).
DHR4 Is Required for Repressing Ecdysone Pulses
To test whether the precocious ecdysone signaling in the mid-
L3 larvae could be linked to the inappropriate timing and/or
duration of a preceding ecdysone pulse, we measured ecdysone
titers during the first 24 h of the L3 using a 20E EIA immunoassay
(Cayman Chemical). The antibody appears to have similar
affinities for 20E and its immediate precursor, ecdysone (E) (Naoki
Yamanaka, personal communication), and therefore titers likely
reflect a combination of both ecdysteroids. We find that knocking
down DHR4 in the RG overall results in significantly higher
ecdysteroid levels at all time points we examined (Figure 2C).
Importantly, while we can resolve two minor ecdysteroid peaks in
the control, we observe no recession of the first L3 pulse in
P0206.DHR4-RNAi larvae (Figure 2C, 16 h time point). Rather,
the first and the second L3 pulse appear to be fused in RNAi
animals, demonstrating that the first pulse was not properly
repressed. It is likely that the combination of higher hormone
levels and the inability to repress the first pulse causes the
premature effects observed for Sgs-4 and E74 transcripts, as well as
the acceleration of wandering behavior and pupariation.
Overexpression of DHR4 in the PG Blocks Molting by
Suppressing Ecdysone Pulses
The derepression of ecdysone titers and the premature ecdysone
signaling in DHR4-RNAi larvae suggest that the wild type function
of this nuclear receptor is to inhibit ecdysone production and/or
release. To test this idea, we reasoned that increasing DHR4
expression specifically in the PG using the phmN1- and P0206-Gal4
drivers should maintain low systemic ecdysone levels and prevent
ecdysone pulses from occurring. Indeed, we found that DHR4
blocks molting when overexpressed in the PG, however the
penetrance of this phenotype is dependent on the driver/
responder combination being used, as well as the chromosomal
location of the transgene, suggesting that this effect is dose-
sensitive. For instance, when UAS-DHR4 (inserted on 2
nd or 3
nd
chromosome) is used in combination with phmN1-Gal4, animals
cannot progress beyond the L1 stage (Figure 2D). Similarly, using
P0206.DHR4/3 (inserted on the 3
rd chromosome) results in all
larvae being trapped in the L2 stage (Figure 2E), while
P0206.DHR4/2 (inserted on the 2
nd chromosome) allows 5%–
10% escapers to reach the pupal stage. To test whether the DHR4-
mediated block in molting could be rescued by ecdysone, we
added 20E to the medium and scored the percentage of animals
that progress to later stages. Regardless of the driver used, we
observed significant rescue when 20E was added to the diet. In the
presence of the hormone, ,80% of the phmN1.DHR4/3 animals
progress to the L2 stage, with another 20% reaching the L3
(Figure 2D). Similarly, most of the P0206.DHR4/3 animals molt
to the L3 in the presence of 20E, and ,4% of the population
pupariate (Figure 2E). Next, we tested whether the ability of DHR4
to block molting was specific to the PG. Since the phmN1-Gal4
driver shows some expression in the fat body, we expressed DHR4
specifically in the fat body using the Cg-Gal4 driver. Similar to the
results obtained with the PG drivers, we observe a developmental
arrest in the L1 and L2 stages. In contrast to overexpressing DHR4
in the PG, however, the developmental arrest caused by fat body-
driven expression of DHR4 cannot be rescued with 20E
(Figure 2F). Taken together, these results demonstrate that
expressing DHR4 in the PG blocks molting and interferes with
systemic 20E levels in a DHR4-dose-dependent manner, where a
stronger Gal4 driver leads to animals trapped in earlier stages.
We further characterized the ability of phmN1.DHR4 expres-
sion to block larval development. Closer examination revealed that
these animals survive and continue to grow for up to 10 d as first
instar (L1) larvae. These L1 larvae grow very large, accumulate
lipids in their fat bodies, and have larger organs than controls due
to continued proliferation (Figure 2G,H). This demonstrates that
expression of DHR4 in the PG specifically blocks molting and does
not trigger lethality. Rather, it appears that these animals simply
lack the ecdysone pulse to molt to the next stage and that all other
aspects of larval life function normally.
The Subcellular Localization of DHR4 Oscillates between
Cytoplasm and Nucleus
We previously reported that DHR4 is highly enriched in the
cytoplasm of PG cells, even though the protein is nuclear in fat body
cells in late L3 larvae [35]. Therefore, it appears that the subcellular
localization of DHR4 is differentially controlled in these two tissues,
raising the question as to whether DHR4 can enter the PG nucleus
at all and, if so, how this translocation is regulated. To test whether
DHR4 could enter the nucleus of PG cells at certain times during
larval development, we stained ring glands isolated from carefully
staged L3 larvae ranging from 0 to 36 h after the molt with affinity-
purified DHR4 antibodies. Using this approach, we found that the
subcellular localization of DHR4 changes periodically in PG cells
during the L3. DHR4 appears to be entirely nuclear at 0, 8, 24, and
36 h,completely cytoplasmicat 4,12,and 20 h,and present inboth
compartments at 16, 28,and 32 h after the L2/L3 molt(Figure 3A).
During the first 36 h of the L3, DHR4 completes at least three
cycles: It shifts from the nucleus to the cytoplasm and back during
the first 8 h after the molt, while the next two cycles last 16 and
12 h, respectively (Figure 3B). These three oscillations show an
intriguing correlation with the occurrence of the three low titer
pulsesduringthe L3.In particular, based on directmeasurements of
20E titers [8] and indirect assessments based on ecdysone-regulated
gene profiling in L3 larvae [11], the three minor 20E pulses have
been mapped to 8, 20, and 28 h after the L2/L3 molt. It should be
noted that 20E constitutes the final and active form of the molting
hormone, and that a biosynthetic profile in the PG of its immediate
phmN1.DHR4/3 cDNA in the PG gives rise to very large L1 larvae (right) when compared to newly molted L2 phmN1.w
1118 control larva (left). (H)
Central nervous systems (CNS) were isolated from larvae equivalent to those pictured in ‘‘G’’ and stained with DAPI. The scale bars represent 25 mm.
(D–H) DHR4/3: UAS-DHR4 cDNA inserted into the 3
rd chromosome.
doi:10.1371/journal.pbio.1001160.g002
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20E curve. Taking this into account, it appears that DHR4 is
cytoplasmic during a minor pulse, but nuclear between these peaks,
consistent with the idea that DHR4 regulates the timing of these
peaks.
In this context it is also important to note that PTTH mRNA was
shown to cycle with an 8-h periodicity in staged L3 larvae [30],
raising the possibility that a causal link exists between the cyclic
behaviors of PTTH expression and DHR4 localization. PTTH acts
through Ras signaling, and larvae that express constitutively active
Ras in their prothoracic glands (phm22.Ras
V12) display shortened
larval stages and small pupae [33], which are strikingly similar to
DHR4 loss-of-function phenotypes. We therefore investigated
whether DHR4 acts in the PTTH pathway.
DHR4 Oscillation Depends on the PTTH Pathway
To examine the impact of altered PTTH activity on the
subcellular distribution of DHR4, we analyzed the location of the
DHR4 protein in PGs isolated from 0- to 8-h-old L3 larvae, which
were carefully staged at the L2/L3 molt. We reasoned that this
stage would not only allow us to follow DHR4 protein through an
entire cycle, but also ensure that these animals are as precisely
timed as possible. Manipulating components of the PTTH
pathway affects developmental timing, which makes later time
points difficult to compare between the different genotypes. To test
the effects of genetically removing PTTH function, we ablated
PTTH-producing neurons in ptth.grim transgenic animals. In
PTTH-abolished animals, DHR4 accumulated in the nucleus,
with some residual protein residing in the cytoplasm (Figure 4).
Ring glands from later L3 time points look comparable
(unpublished data), strongly suggesting that nuclear export and/
or degradation of DHR4 is abrogated when PTTH signaling is
disrupted. To validate these findings, we examined the effects of
torso RNAi, which targets the PTTH receptor. Very similar to the
PTTH ablation line, we observed nuclear enrichment of DHR4
and loss of oscillation in phm22.torso-RNAi animals (Figure 4). We
surmised that hyperactivating the PTTH pathway via constitu-
tively active Ras
V12 [34] should result in cytoplasmic rather than
nuclear accumulation of DHR4. To test this, we carried out
DHR4 antibody stains on ring glands isolated from phm22.Ras
V12
larvae. In contrast to the nuclear accumulation observed in larvae
without intact PTTH signaling, we found strong cytoplasmic
enrichment of DHR4 in PG cells when Ras
V12 was expressed
(Figure 4), indicating that Ras activity dictates whether DHR4 can
accumulate in the nucleus or not. Note that constitutively active
Ras
V12 results in overproliferating PGs, explaining the large and
malformed glands we observe.
Figure 3. DHR4 oscillates between cytoplasm and nucleus in PG cells of L3 larvae. (A) Confocal images of ring glands isolated from
carefully staged w
1118 L3 larvae at different times relative to the L2/L3 molt. Ring glands were stained with affinity-purified DHR4 antibody. 15–20 ring
glands were tested per time point. (B) Schematic representation of DHR4 oscillations. The three cycles observed in (A) correlate with the appearance
of the three minor 20E pulses that are documented for the L3 [8]. These pulses likely induce the Lsp1, Sgs, and E75A genes [11]. N, nucleus.
doi:10.1371/journal.pbio.1001160.g003
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controls DHR4 and that nuclear accumulation of the protein is
only permitted when the pathway is inactive. This suggests that
PTTH regulates DHR4 activity by controlling its subcellular
localization, thereby permitting or preventing access of DHR4 to
its target genes.
Ras
V12 Prevents the Nuclear Localization of DHR4 in Fat
Body Cells
To further examine the ability of Ras
V12 to prevent DHR4 from
entering the nucleus, we tested whether Ras
V12 could abolish
DHR4 nuclear localization in larval fat body cells, where DHR4
was shown to be restricted to the nucleus once translation has
occurred, at least in L2 and L3 larvae (Figures 5A, S1) [35]. When
we specifically drive expression of UAS-Ras
V12 in the fat body using
Cg-Gal4, we found DHR4 to be virtually absent from the nuclei
and to be strongly enriched in the cytoplasm instead (Figure 5B),
indicating that constitutively active Ras is sufficient to trigger
cytoplasmic retention of DHR4. These findings corroborate our
results obtained from the PG, providing strong evidence that
nucleocytoplasmic distribution of DHR4 is controlled by PTTH
signaling.
DHR4 Overexpression in the PG Rescues Ras
V12
Phenotypes
The dependence of DHR4 on Ras is intriguing because Ras
V12
is—to the best of our knowledge—the only other known genetic
alteration besides the DHR4
1 mutation that results in accelerated
larval development and small pupae [33,43]. We also observe the
occurrence of dwarf larvae in Ras
V12 animals (Figure 1B). These
findings are consistent with our observation that Ras
V12 prevents
DHR4 from accumulating in the nucleus, thus disrupting its
nuclear functions, similar to DHR4
1 mutants or DHR4-RNAi
animals. Based on this observation, one would predict that some of
the effects of Ras
V12 could be blocked if one increases the level of
DHR4 protein in the same tissue. We therefore asked whether
DHR4 was epistatic to Ras or, more specifically, if we could rescue
Ras
V12-induced phenotypes by overexpressing DHR4 specifically in
the PG. First, we determined the average time to puparium
formation when Ras
V12 or DHR4, or both together, are expressed
in the ring gland using the P0206-Gal4 driver. As mentioned
previously, ,5%-10% of P0206.DHR4/2 larvae reach the
prepupal stage, allowing us to determine their timing profiles. As
previously reported by others, P0206.Ras
V12 animals develop
much faster than controls [33,43], preceding the appearance of
control prepupae by ,20 h (Figure 5C). In contrast,
P0206.DHR4/2 prepupae form with a ,20-h delay compared
to controls. However, when Ras
V12 and DHR4 are expressed
together in the PG, we observe normal timing of pupariation, and
a partial rescue of the DHR4-mediated lethality (Figure 5C).
Since Ras
V12 overexpression results in a hyper-proliferation
phenotype (Figures 4, 5B), we wondered whether this aspect of Ras
activity could also be rescued by DHR4 overexpression. For this,
we examined the morphology of ring glands isolated from staged
L3 larvae that express Ras
V12 and/or DHR4. P0206.Ras
V12 larvae
have very large ring glands, while DHR4 expression using the same
driver results in slightly smaller ring glands compared to controls
(Figure 5D). Importantly, when DHR4 is co-expressed with Ras
V12,
hyper-proliferation of the ring gland appears to be repressed,
strongly suggesting that increasing levels of DHR4 in this tissue
blocks Ras activity.
Nuclear Localization of ERK/MAPK and DHR4 Are
Inversely Correlated
PTTH acts on the PG by ultimately activating ERK, a MAP
kinase, via phosphorylation. Upon activation, ERK can enter the
nucleus and phosphorylate nuclear target proteins such as
transcription factors or other kinases [44]. Since a key role of
PTTH is the induction of ecdysone biosynthesis, and DHR4
appears to have the opposite function, we would predict that
PTTH activity would remove nuclear DHR4 via activated ERK
entering the nucleus. We therefore stained ring glands from staged
early L3 larvae to examine the subcellular localization of ERK at
various time points. At 0 and 8 h after the L2/L3 molt, we found
ERK evenly distributed between nucleus and cytoplasm, however
at the 4-h time point, ERK is strongly enriched in the nucleus
(Figure 5E). We conclude that ERK shows an inverse relationship
to DHR4, at least at the examined time points: ERK accumulates
in the nucleus when DHR4 is enriched in the cytoplasm, and
when DHR4 is abundant in the nucleus, we found no particular
increase of nuclear ERK over cytoplasmic ERK. These data are
Figure 4. Effects on DHR4 subcellular localization by manipu-
lating PTTH pathway components. DHR4 antibody stains.
phm22.w
1118 and ptth.w
1118 ring glands serve as controls. The
ptth.grim and phm22.torso-RNAi lines disrupt PTTH signaling.
phm22.Ras
V12 constitutively activates the PTTH pathway. Hours
indicate time after the L2/L3 molt. 10–15 ring glands were tested per
condition.
doi:10.1371/journal.pbio.1001160.g004
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of DHR4 from the PG nuclei in response to PTTH, in line with
our findings that the subcellular localization of DHR4 is regulated
by the PTTH/Ras/Raf/ERK signaling pathway.
DHR4-RNAi Ring Gland Microarrays Reveal Misregulation
of Cytochrome P450 genes
To identify possible target genes of DHR4, we triggered RNAi
in late L2 using hsDHR4-RNAi and carried out microarray
analysis of ring gland RNA isolated from larvae staged at 4 and
8 h after the molt. To reduce the number of false positives, we
analyzed two adjacent time points, 4 and 8 h after the L2/L3
molt, allowing us to select for genes that exhibit significant
expression changes at both time points. Using a stringent filtering
approach we identified 54 genes whose transcript levels showed a
greater than 4-fold difference between controls and DHR4-RNAi
animals at both time points (Figure 6A). Selected genes from these
54 genes are shown in Figure 6B and C. Intriguingly, among these
54 genes are four cytochrome P450 genes, an enrichment that is
highly unlikely to occur by chance (p value=2.4E-11). Two of the
P450 genes are downregulated (Cyp6a17 and Cyp9c1), while the
other two show increased expression (Cyp6t3 and Cyp6w1), and the
effects are very similar between the two time points (Figure 6D, left
panels). We also found a short-chain dehydrogenase/reductase
(CG2065) among the affected genes, which belongs to the same
enzyme family as the Halloween gene shroud. Finally, CG16957,
which encodes a protein with a cytochrome b5 domain, is also
affected by DHR4-RNAi. This protein family is functionally
related to cytochrome P450 enzymes because both enzyme classes
act as oxidoreductases and carry heme groups.
To validate some of these observations, we analyzed the
expression of all four affected cytochrome P450 genes in brain-ring
gland complexes isolated from hsDHR4-RNAi animals as well as
DHR4
1 mutants that were staged at 4 h after the L2/L3 molt. We
also included the analysis of the Halloween genes sad, dib, and phm
as additional controls, in case these genes were affected, but not
identified by the microarray approach. As expected, all four
cytochrome P450 genes identified by the array display very similar
profiles in the qPCR validation experiments (Figure 6D, right
panels). When we analyzed the samples derived from the DHR4
1
mutants, we confirmed that Cyp6t3 and Cyp6w1 are significantly
higher when DHR4 function is impaired. However, we found that
Figure 5. DHR4 acts downstream of Ras and ERK. (A, B) DHR4 antibody stains (red) of Cg.w
1118 (A) and Cg.Ras
V12 (B) late L2 fat body cells.
Blue: DAPI stain of nuclei. (C) Genetic epistasis analysis examining the timing of pupariation for transgenic lines expressing DHR4 cDNA, Ras
V12,o r
both. Percentages indicate the fraction of embryos that developed into prepupae at a given time point. All populations were tested in triplicate, total
N in brackets. Genotypes: P0206.Ras
V12 (red, N=151), P0206.w
1118 (blue, N=223), P0206.DHR4/2; Ras
V12 (black, N=293), and P0206.DHR4/2
(green, N=265). Error bars represent standard deviation. (D) DHR4 overexpression inhibits Ras
V12-induced ring gland overgrowth. CNS-RG complexes
isolated from early L3 larvae, pictures show same sample at 206and 406magnification. Blue: DAPI. Green: UAS-mCD8-GFP is recombined to the same
chromosome as P0206-Gal4, and therefore reflects the expression pattern of the P0206 driver. Genotypes are listed below the figure. The scale bars
represent 25 mm. (C–D) DHR4/2 denotes UAS-DHR4 cDNA inserted in the 2
nd chromosome. (E) Upper panel: Anti-ERK antibody stains of L3 RGs
isolated at 0, 4, and 8 h after L2/L3 molt. Lower panel: Nuclei stain with DAPI. (D–E) 10–15 ring glands were stained per condition.
doi:10.1371/journal.pbio.1001160.g005
DHR4 Controls Timing of Steroid Hormone Pulses
PLoS Biology | www.plosbiology.org 9 September 2011 | Volume 9 | Issue 9 | e1001160Figure 6. DHR4-RNAi ring gland microarray reveals misregulated cytochrome P450 genes. (A) Comparison of microarray data sets
representing 71 genes upregulated or downregulated more than 4-fold in 4-h L3 and 81 genes in 8-h L3 hsDHR4-RNAi ring glands. Filtering criteria:
$4-fold change, Student’s t test with a p value of ,0.05 for both time points, and an ANOVA p value of ,0.01. (B, C) Selected genes either
downregulated (B) or upregulated (C), sorted by the 4-h p value. Genes with possible roles in ecdysone biosynthesis are in bold. # indicates three
different probe sets were detected for Ir76a. (D) Selected microarray results and qPCR validation in hsDHR4-RNAi animals and DHR4
1 mutants (grey
DHR4 Controls Timing of Steroid Hormone Pulses
PLoS Biology | www.plosbiology.org 10 September 2011 | Volume 9 | Issue 9 | e1001160Cyp9c1 displayed higher rather than lower levels compared to
controls. In addition, we were unable to detect Cyp6a17 in DHR4
1
mutants or in the corresponding parental line, P427, suggesting
that both Cyp9c1 and Cyp6a17 expression varies substantially
between different genetic backgrounds. Future experiments will
address whether Cyp9c1 or Cyp6a17 are dependent on DHR4
function. Our qPCR analysis revealed no substantial effects on the
tested Halloween genes (Figure 6D, all panels), confirming the
microarray results. Taken together, our microarray data identified
two cytochrome P450 genes, Cyp6t3 and Cyp6w1, which display
significantly higher expression levels in the ring glands of hsDHR4-
RNAi animals as well as in brain-ring gland complexes isolated
from DHR4
1 mutants, indicating that DHR4 normally represses
these genes.
Cyp6t3 Has a Novel Role in the Biosynthesis of Ecdysone
Of the two cytochrome P450 genes reproducibly affected by
loss-of-DHR4 function, Cyp6t3 and Cyp6w1, we chose to analyze
Cyp6t3 in more detail for two reasons. First, Cyp6t3, but not
Cyp6w1 (unpublished data), is specifically expressed in the ring
gland based on qPCR analysis, which shows ,20-fold enrichment
of Cyp6t3 transcripts in the ring gland compared to whole body
(Figure S4). We confirmed this by in situ hybridization, which
demonstrates that Cyp6t3 is specifically expressed in the protho-
racic glands and the corpus allatum (Figure 7E). Bleed-through of the
tyramide-amplified signal did not allow us to determine whether
Cyp6t3 is also expressed in the corpora cardiaca. Second, when we
examined the changes in gene expression at 0, 4, 8, and 12 h after
the L2/L3 molt, we found that Cyp6t3 levels, but not Cyp6w1
levels, oscillate during this time window, where lower concentra-
tions of Cyp6t3 correlate with nuclear DHR4, consistent with the
idea that DHR4 represses this gene (compare Figures 7G and S5
with Figure 3A). For these reasons we examined whether
interfering with Cyp6t3 function in the PG via RNAi results in
any developmental defects. Specifically, we expressed Cyp6t3
RNAi (VDRC #109703) [45] in the PG by generating
phm22.Cyp6t3-RNAi animals. Disrupting Cyp6t3 in this manner
generates phenotypes typically observed in mutants that have
defects in the ecdysone synthesis pathway [30,38,46,47]. For
instance, we observe very large pupae (similar in size to phantom
(phm) and disembodied (dib) RNAi pupae, Figure 7A), double larval
mouthhooks (a common molting defect, Figure 7A inset), and L2
prepupae (Figure 7A). The latter phenotype occurs when larvae
forego the molt to an L3 and directly molt from an L2 to a
prepupa. This phenotype is relatively rare and has been only
associated with mutations in E75 [46], dre4 [48], and itpr [49], all
of which have dramatically lowered ecdysone levels. We also tested
a second independently generated Cyp6t3 RNAi line (VDRC
#30896, Figure S6), which is based on a smaller dsRNA construct.
In this RNAi line, we also observe very large pupae, consistent
with a longer feeding period, but failed to identify any L2
prepupae. Feeding 20E to these animals completely rescues the
large body size (Figure S6). Since the VDRC line #109703 was
stronger than the #30896 line, we continued our studies with the
former line. No phenotypes are observed when Cyp6t3-RNAi is
expressed in the fat body (unpublished data), indicating that the
phenotypes induced by phm22.Cyp6t3-RNAi are specific to the
PG.
Next, we examined whether Cyp6t3-RNAi animals have lower
ecdysone titers. To test this, we compared ecdysteroid concentra-
tions at multiple time points between L3 control larvae and
delayed L2 larvae of the same absolute age. The latter ultimately
develop into L2 prepupae. As expected, Cyp6t3-RNAi larvae have
severely reduced ecdysteroid titers compared to controls, but
generate a small pulse before they form L2 prepupae (Figure 7B,
100 h L2 time point). In addition, we also measured ecdysteroid
concentrations in earlier stages and found that Cyp6t3-RNAi
animals have lower hormone levels at all larval stages, but not as
embryos (Figure S7). One would predict that feeding ecdysone to
phm22.Cyp6t3-RNAi animals should rescue at least some of the
phenotypes, and indeed we observed that the occurrence of L2
prepupae is completely rescued when 20E is added to standard
medium (Figure 7C), corroborating our finding that
phm22.Cyp6t3 RNAi affects ecdysone production. To further
characterize at which step in the ecdysone biosynthetic pathway
Cyp6t3 might act, we examined which 20E precursors might also
result in a rescue. For this, we took advantage of the fact that the
Cyp6t3-RNAi phenotype was more pronounced on an instant
medium (4–24, Carolina Biological Supply Company), hereafter
referred to a ‘‘C424.’’ This medium is naturally low in cholesterol
and other sterols, and has been used by us for sterol rescue studies
before [50]. On this medium, phm22.Cyp6t3-RNAi animals very
rarely progress beyond the L2/L3 molt (,0.5%), either dying as
L2 larvae or L2 prepupae. When we supplemented C424 with
carrier only (ethanol), cholesterol, or 7-dehydrocholesterol (7dC),
we failed to see any rescue, defined by larvae developing to L3
larvae or later stages. In contrast, adding E or 20E to C424
medium resulted in .60% rescue, while supplementation with 5b-
ketodiol rescued ,15% of the Cyp6t3-RNAi population past the
L2/L3 molt (Figure 7D), with some animals reaching the pupal
stage (unpublished data). The lower percentage of rescued animals
with 5b-ketodiol likely reflects the fact that this compound has to
enter the PG, while E and 20E can act directly on the target
tissues. This strongly suggests that Cyp6t3 plays a role in the black
box, since mutations affecting enzymes acting downstream cannot
be rescued with 5b-ketodiol [21,24].
Cyp6t3 Is Epistatic to DHR4
While our data demonstrate that Cyp6t3 is specifically expressed
in the ring gland, it appears to be expressed at a fairly low level.
Based on our microarray and qPCR experiments we estimate that
in the ring gland, Cyp6t3 transcript levels are two orders of
magnitude lower than those of phm, dib, and sad. A possible
explanation for this is that Cyp6t3 forms part of a ‘‘bottleneck’’ for
ecdysone production and that a low abundance of transcripts
renders Cyp6t3 more susceptible to transcriptional regulation than
its Halloween counterparts. We therefore wondered whether (a)
overexpression of Cyp6t3 would be sufficient to alleviate this
bottleneck and accelerate ecdysone synthesis and development and
(b) if loss of Cyp6t3 function in a DHR4
1 mutant background is
necessary for accelerated development of these animals. In the first
experiment, we generated a phm22.Cyp6t3 line that expresses a
Cyp6t3 cDNA at high levels in the PG [51]. This resulted in no
obvious phenotypes with respect to timing or overall morphology
(unpublished data), suggesting that Cyp6t3 is not sufficient to
accelerate developmental timing via an increased rate of ecdysone
bars). Controls are shown in black, w
1118 for hsDHR4-RNAi and P427 for DHR4
1 mutant. Shadow, dib, and phantom failed ANOVA testing at the 95%
level, but were included for validation purposes. RNA from brain-ring gland complexes of animals staged at 4-h L3 was used for qPCR validation. Error
bars for the array data represent standard deviation, and error bars for qPCR data show 95% confidence intervals. Asterisks indicate significant
differences between groups (* p,0.05, ** p,0.005, *** p,0.0005, **** p,0.00005 by Student’s t test).
doi:10.1371/journal.pbio.1001160.g006
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1;
phm22.Cyp6t3-RNAi larvae display delayed instead of accelerated
development relative to w
1118 controls (Figure 7F). This indicates
that upregulation of Cyp6t3 in DHR4
1 mutants (Figure 6D) is
necessary for the accelerated development in these animals, and
that lowering the levels of Cyp6t3 via RNAi effectively abolishes
this effect. We conclude that Cyp6t3 is necessary but not sufficient
for accelerating development, suggesting that if Cyp6t3 is indeed
part of a bottleneck, it is not acting alone in this rate-limiting step.
Discussion
DHR4 Oscillation and Its Dependence on PTTH Signaling
A series of reports have provided ample evidence that PTTH
utilizes the Ras/Raf/ERK pathway to regulate ecdysone biosyn-
thesis in Bombyx, Manduca, and Drosophila [33,52–56]. In the present
study, we demonstrate that a critical readout of this pathway is the
nuclear receptor DHR4. We suggest a simple model where PTTH
represses DHR4 activity via its removal from the nucleus, while
DHR4 in turn represses the occurrence of low-titer ecdysone peaks
when nuclear (Figure 8). In laboratory fly cultures, PTTH was
shown to be a non-essential gene, however when PTTH-producing
neurons are ablated, development is substantially delayed and
animals have a concomitant increase in body size [33]. We show
here that disrupting DHR4 specifically in the PG results in opposite
phenotypes to loss-of-PTTH function, where animals are smaller
and develop faster than controls. Like PTTH ablation lines, animals
homozygous for P0206.DHR4-RNAi can be kept as a viable stock,
consistent withthe idea that DHR4 functionsin the PG as a PTTH-
dependent, non-essential developmental clock to generate appro-
priately timed ecdysone pulses. It is of interest to note that the
expression of constitutively active Ras in the PG of P0206.Ras
V12
animals results in accelerated larval development and small pupae,
very similar to DHR4
1 mutants and P0206.DHR4-RNAi animals.
P0206.Ras
V12 animals are also viable, and we showed that L3
larvae of this genotype accumulate DHR4 in the cytoplasm of PG
cells (Figure 4). This strongly suggests that P0206.Ras
V12 larvae
display these phenotypes precisely because DHR4 protein is
prevented from entering PG nuclei, thereby mimicking the loss-
of-function phenotypes observed in DHR4 RNAi or mutant larvae.
We have demonstrated that the PTTH pathway controls the
subcellular location of DHR4. Loss of PTTH signaling results in
nuclear presence of DHR4, while constitutively activating this
pathway leads to cytoplasmic localization of the protein. It is
unclear at this point whether the DHR4 oscillations represent
shuttling or involve cycles of degradation and synthesis. Shuttling
would require a stable DHR4 protein that moves in and out of the
nucleus, however this would be difficult to reconcile with the fact
that DHR4 RNAi works well in our hands, since a continuously
shuttling protein would be impervious to RNAi. It is evident that
sufficient turnover of the DHR4 protein must occur, at least
around the L2/L3 molt, when we conducted our heat-induced
DHR4-RNAi experiments (Figures 1D–E, 2B, and S3). This raises
the question of whether DHR4 mRNA levels are oscillating, given
that the degraded protein must be replaced periodically. When we
conducted a time course microarray of wild type ring glands, we
observed very low and constant levels of DHR4 mRNA, which
does not support the idea that DHR4 transcripts levels are
oscillating (Ou et al., manuscript in preparation). Based on these
data, we suspect that DHR4 mRNA is highly stable in PG cells and
translated when needed in L3 larvae. Alternatively, our current
approach might be too insensitive to detect periodic changes in
DHR4 mRNA levels.
It was shown in mammalian cell cultures that the ERK pathway
controls the subcellular localization of the nuclear receptor
PPARc. Specifically, mitogenic stimulation of resting cells causes
the binding of nuclear MEK1 to PPARc, which is followed by
rapid export of the protein complex from the nucleus [57,58]. Our
study does not provide direct evidence that DHR4 is phosphor-
ylated. However, our data are suggestive of the idea that ERK
plays a role in removing DHR4 from the nucleus, since we found
that ERK changes its nucleo-cytoplasmic distribution in early L3
larvae, in an apparent inverse relationship to DHR4, consistent
with the notion that it acts upstream of this nuclear receptor
(Figure 5E). Future experiments will have to examine whether
DHR4 is a direct target of ERK and whether phosphorylation
plays a role in the nucleo-cytoplasmic oscillations of DHR4.
An intriguing finding is that Drosophila PTTH mRNA levels
oscillate with an apparent 8-h cycle time throughout the 48-h
duration of the L3 stage [30]. DHR4, on the other hand, displays
an 8-h, 16-h, and 12-h cycle time for the first 36 h of the L3 stage,
raising the question as to how these ultradian periods are
established. What could account for the difference in these cycle
times? A simple possibility is that we were unable to detect all
DHR4 cycles and that the DHR4 oscillations are well aligned with
the PTTH cycles. In this study, we chose to conduct a time course
based on a 4-h step size, because we consider 4 h a robust time
interval that should compensate for the inherent asynchrony that
exists in developing Drosophila larvae. We examined 15–20 ring
glands per time point, and only found some discrepancies among
ring glands from later time points, likely due to the asynchronous
development of the population. However, it appears that during
Figure 7. Functional characterization of Cyp6t3. (A) PG-specific Cyp6t3-RNAi phenotypes VDRC #109703), compared to phm22.w
1118 control
(left). Insets show the morphology of anterior spiracles and double mouth hooks of phm22.Cyp6t3-RNAi compared to controls. (B) Whole-body
ecdysteroid titer measurements comparing equivalent L2 and L3 stages between phm22.Cyp6t3-RNAi animals (orange) and phm22.w
1118 controls
(black). Time points indicate hours after the L2/L3 molt (control) or after the L1/L2 molt (phm22.Cyp6t3-RNAi). For every genotype/time point, 3–4
samples (N=30–45 larvae) were each tested in triplicate. Error bars indicate standard error. (C) Feeding ecdysone to Cyp6t3-RNAi larvae rescues L2
pupae phenotype. Percentages of L2 pupae (striped) and L3 pupae (black) of phm22.w
1118 and phm22.Cyp6t3-RNAi in populations fed a standard
medium with or without 20E. Error bars indicate standard deviation, N=150–200 for each condition. (D) Feeding 5b-ketodiol to Cyp6t3-RNAi larvae
rescues larvae beyond the L2 stage. C424 instant fly medium (Carolina) was supplemented with different ecdysteroid precursors or the carrier alone
(ethanol). Percentages show fraction of embryos reaching the L3 stage. Grey: phm22.w
1118. Orange: phm22.Cyp6t3-RNAi. Error bars indicate
standard deviation, N=150–200 for each condition. ETOH, ethanol; C, cholesterol; 7dC, 7-dehydrocholesterol; 5bKD, 5b-ketodiol; E, ecdysone; 20E, 20-
hydoxyecdysone. (E) In situ hybridization of Cyp6t3 antisense and sense probes. Early L3 larval CNS-RG complexes with eye-antenna imaginal discs
were examined at 206magnification. A DAPI stain of the nuclei is included. (F) Genetic epistasis analysis examining the timing of pupariation in
animals carrying a DHR4
1 mutation, phm22-Gal4//Cyp6t3-RNAi transgenes, or both. Percentages were normalized to the final number of pupae for
each genotype and represent the fraction of larvae that formed pupae at a given time point. DHR4
1 mutants (red, N=54), phm22.w
1118 (black,
N=180), phm22.Cyp6t3-RNAi (orange, N=600), and DHR4
1; phm22.Cyp6t3-RNAi (blue, N=107). (G) Transcriptional profile of Cyp6t3 in early L3.
Brain-ring gland complexes were dissected from carefully staged w
1118 larvae of indicated time points. Fold changes are relative to 0 h after the L2 to
L3 molt. Error bars in (G) represent 95% confidence intervals. p values (Student’s t test) are relative to the previous time point. (B,C,D,F) Cyp6t3i: short
for Cyp6t3-RNAi.
doi:10.1371/journal.pbio.1001160.g007
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in the nucleus and the cytoplasm, and it is possible that this reflects
a transition phase of a cycle we might have missed. Future studies
could attempt a time course with a 2-h step size, ideally in
combination with a Sgs3-GFP reporter line to re-stage animals in
the mid third instar [8].
Alternatively, the differences in cycle duration between DHR4
and PTTH could reflect the possibility of another cyclicprocess that
may contribute to the timing of DHR4 periodicity. An attractive
possibility is that circadian rhythms are superimposed on the PTTH
oscillations to determine DHR4 cycle times. Anatomical evidence
indicates that the central circadian pacemaker cells found in the
Drosophila brain, the Lateral Neurons, indirectly innervate the PG
[59]. A critical effector of these neurons is the neuropeptide PDF
(Pigment Dispersing Factor), and a mutation in pdf alters the
periodicity of PTTH mRNA oscillations [30]. Future experiments
will address whether PDF and other components of the circadian
clock impinge on the oscillatory behavior of DHR4 in PG cells.
PTTH and the Transcriptional Control of Ecdysone
Biosynthetic Genes
The mechanism by which PTTH regulates ecdysone biosyn-
thesis has been the subject of intense research for the last 35 years.
PTTH triggers a complex array of signaling events in the PG that
precede the synthesis of ecdysone. These include second
messengers like Ca
2+ influx and the synthesis of cAMP, followed
by the stimulation of Protein kinase A, the activation of p70S6K
and the concomitant phosphorylation of ribosomal protein S6, a
myriad of tyrosine phosphorylations, as well as the activation of
the ERK pathway discussed in this report [56]. Clearly, PTTH
triggers a range of events, which, among others, results in the
transcriptional upregulation of genes required for ecdysteroid
biosynthesis. The first evidence that PTTH is sufficient to increase
transcript levels of an ecdysteroidogenic gene is based on the
observation that the Bombyx disembodied gene (dib-Bm) is upregulated
by administering PTTH to cultured prothoracic glands [32]. The
upregulation of phm and spo appears to be more moderate [31,32],
Figure 8. Models for DHR4 function. DHR4 represses ecdysone pulses dependent on whether PTTH signaling is active or inactive (middle panel).
In the presence of PTTH signaling (upper panel, left), DHR4 is removed from the nucleus either by shuttling to the cytoplasm or by protein
degradation, which allows for ecdysone biosynthesis to occur. In the absence of PTTH (lower panel), DHR4 remains in the nucleus and represses
Cyp6t3 and possibly other genes with roles in ecdysone production, thereby lowering ecdysone titers. During molts, DHR4 acts as a component of the
EcR-controlled gene hierarchy in some target tissues of the hormone (upper panel, right). See text for details.
doi:10.1371/journal.pbio.1001160.g008
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conditions [32]. Attempts to generate functional recombinant
Drosophila PTTH have so far been unsuccessful [33], but loss-of-
function studies have confirmed a role for PTTH in the
transcriptional regulation of ecdysteroidogenic genes. Specifically,
ablation of PTTH-producing neurons resulted in a strong
reduction of Drosophila dib (,10-fold down) and had a moderate
effect on phm, sad, and spok (2–3-fold down). While similar studies
with a torso RNAi line have not been published, indirect results
come from a recent paper where the authors knocked down
dSmad2 function in the PG, which results in a strong downregu-
lation of torso [60]. Concomitantly, spok and dib are strongly
reduced in phm.dSmad2-RNAi larvae, but similar to the above
findings, no effect was seen for phm and sad. Taken together, the
findings from Bombyx and Drosophila seem to suggest that the
transcriptional effect of PTTH is most clearly established for dib,
while phm and sad appear to be less dependent on PTTH signaling.
One aspect of PTTH-mediated transcriptional regulation that has
not been satisfactorily addressed is whether some of the
ecdysteroidogenic genes require PTTH to reach high expression
levels in the first place or whether the hormone provides a ‘‘boost’’
to elevate transcript levels even further. According to our RG
microarray and qPCR data presented here, we conclude that
expression levels of the Halloween genes are very high in L3
larvae, comparable to that of ribosomal genes. We also conducted
a microarray time course (Ou et al., manuscript in preparation),
which suggests that the Halloween genes are expressed at very
high levels during the first 36 h of the L3, without much
fluctuation in their expression levels. Therefore, it would seem
unlikely, at least according to our data, that transcriptional
downregulation of the highly expressed ecdysteroidogenic genes
like dib or phm can be the mechanism by which the three minor
ecdysone peaks are generated, which is in line with our finding
that knocking down DHR4 in the RG has no effect on phm, sad,
and dib (Figure 6D). Rather, it appears that DHR4 negatively
regulates Cyp6t3 and possibly other uncharacterized genes that
play critical roles in the production of ecdysone (Figure 8).
DHR4 appears to mainly act as a repressor [35], similar to what
has been reported for its vertebrate ortholog GCNF [61]. It
remains to be seen whether the genes that are downregulated in
our hsDHR4-RNAi microarrays are indirect targets of DHR4 or
whether this nuclear receptor can act as an activator on some
promoters. We have previously shown that DHR4 acts down-
stream of the 20E receptor EcR as a key component of the
ecdysone hierarchy during puparium formation [35]. It therefore
appears that DHR4 acts upstream of ecdysone in the PG, but
downstream of the hormone in target tissues (Figure 8), which
nicely reflects the duality of DHR4
1 mutant phenotypes: the
mutation affects developmental timing (due to its role in the PG)
and puparium formation (due to its role in the fat body).
While some transcription factors have been identified for their
roles in the ecdysone production pathway, none have been
reported to repress ecdysteroidogenesis, and none have been
directly linked to PTTH. A mutation in the woc (without children)
gene, which encodes a putative zinc finger transcription factor,
causes low ecdysone levels. This phenotype can be rescued with
feeding 7-dehydrocholesterol (7dC), suggesting that Woc might
control the conversion of cholesterol to 7dC by regulating the
genes required for this step [62]. The nuclear receptor bFTZ-F1 is
expressed in the PG of late L3 larvae and is required for normal
levels of Phm and Dib protein [27]. Another nuclear receptor,
E75A, acts in a feed-forward loop to maintain normal ecdysone
levels, possibly by acting upstream of bFTZ-F1 in the PG [46].
Cyp6t3 Is a Downstream Target of DHR4
Our ring gland microarray and qPCR data revealed that Cyp6t3
transcript levels are significantly elevated in hsDHR4 RNAi
animals and DHR4
1 mutants. In addition, we showed that Cyp6t3
expression levels oscillate during the first 12 h after the L2/L3
molt, with lower levels of Cyp6t3 when DHR4 is nuclear
(Figure 7G). It therefore appears plausible that Cyp6t3 is a direct
transcriptional target of DHR4, however direct evidence for this is
lacking. No DNA recognition sites have been identified for DHR4,
nor is it known whether this nuclear receptor acts as a homodimer,
heterodimer, or monomer. According to our microarray data, as
well as judging by the cycle numbers required to detect Cyp6t3 in
qPCR experiments, we estimate that transcript levels of this gene
are relatively low, probably by two orders of magnitude lower than
the Halloween mRNAs for phm, dib, spookier, and shadow in PG cells
(unpublished data). This is consistent with the finding that Cyp6t3
was previously neither detected by in situ hybridization in any
larval tissue, nor amplifiable from larval cDNA, while the
aforementioned 4 Halloween genes showed strong expression
under the same conditions in the PG of Drosophila larvae [63].
However, using tyramide amplification coupled to in situ
hybridization, we were able to validate the ring gland-specific
expression of Cyp6t3 (Figure 7E). According to our wild type
microarray study, Cyp6t3 is one out of nine cytochrome P450
transcripts that have a higher than 10-fold enrichment in the ring
gland compared to the whole body signal (Ou et al., manuscript in
preparation), supporting the idea that this gene has an important
role in ecdysteroid biosynthesis.
The fact that Cyp6t3 is expressed at very low levels raises the
possibility that the Cyp6t3 enzyme is scarce and therefore rate-
limiting with respect to the production of ecdysone. An attractive
model is that DHR4-mediated repression of Cyp6t3 suffices to
reduce ecdysone production to basal levels. If true, one would
predict that Cyp6t3 turnover is controlled so that transcriptional
control of the Cyp6t3 gene becomes a relevant factor in controlling
ecdysone synthesis. Conversely, derepression of Cyp6t3 due to loss-
of-DHR4 function could result in faster accumulation of ecdysone,
which would account for the timing defects we observe. However,
when we overexpressed a Cyp6t3 cDNA specifically in the PG, we
did not observe any obvious phenotypes or effects on development
timing, suggesting that changing levels of Cyp6t3 alone is not
sufficient for this response (unpublished data). In contrast, we
could show that Cyp6t3 function is necessary for the accelerated
developmental phenotype of DHR4
1 mutants, strongly supporting
the notion that Cyp6t3 is a key target of DHR4-mediated
repression of ecdysone pulses (Figure 7F).
The degree by which Cyp6t3 is repressed might directly
correspond to the amount of DHR4 protein allowed to enter the
nucleus. In support of this idea we find that overexpression of
DHR4 cDNA in the PG results in varying degrees of larval arrest,
depending on the strength of the Gal4 driver being used
(Figure 2D–F), which in turn suggests that the strength of the
phenotype depends on how much DHR4 can enter the nucleus.
Therefore, it is conceivable that the nuclear functions of DHR4
are dose-sensitive, giving rise to the idea that the oscillations of this
nuclear receptor do not necessarily represent an all or nothing
response, but may in fact fine-tune the expression levels of target
genes instead.
An interesting question is whether Cyp6t3 has clearly identifiable
orthologs in other insects species, which is the case for the
Halloween genes [64]. To address this question we conducted a
series of BLAST searches with the Drosophila melanogaster Cyp6t3
amino acid sequence as a query. We limited our search to insect
species with sequenced genomes and aligned the top hits from this
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using the program Seaview (Figure S9) [65]. Due to the large size
of the Cyp450 family 6 [66] and the sequence similarities within
this family, we were not able to identify a definitive Cyp6t3
ortholog outside the Drosophila genus. We reached this conclusion
based on a reverse BLAST search strategy, which revealed that the
top hits from the D. melanogaster query did not retrieve Cyp6t3 as
the best hit when used as queries themselves. Despite this, Cyp6t3
is highly similar to sequences found in other insect species, and it is
likely that very similar paralogs are masking the true ‘‘functional’’
ortholog. Often, reverse BLAST searches fail to reveal definitive
orthologs. For instance, the best characterized nuclear receptor in
Drosophila, EcR, is most similar to both FXR and LXR, depending
on whether one uses the DNA-binding domain or the ligand-
binding domain as a query [67]. Future studies in other insect
species will have to address the question of whether Cyp6t3
orthologs are also important for ecdysone production.
Materials and Methods
Drosophila Stocks
w
1118 (#3605) and UAS-Ras
V12 (#4847) were ordered from the
Bloomington stock center. Gal4 drivers were obtained from labs
indicated by the references. Ring gland: P0206-Gal4, UAS-mCD8-
GFP [68], phm22-Gal4 [33]; phmN1-Gal4 [69]. Fat body: Cg-Gal4
[70]. PTTH-Gal4 driver and PTTH ablation line: UAS-Grim/CyO-
act-GFP & ptth-Gal4/Ser-act-GFP [30]; DHR4
1/FM7h, & hsDHR4-
RNAi[35]; RNAi lines were obtained from Vienna Drosophila RNAi
Center [45]. UAS-Torso-RNAi (VDRC #4300 & #1016); UAS-
Cyp6t3-RNAi (VDRC #109703 & #30896); UAS-phm-RNAi:
(VDRC #100811), UAS-dib-RNAi (VDRC #101117).
Developmental Timing Analysis
Before embryos were collected on grape juice agar plates, flies
were allowed to lay eggs twice for 2 h in order to reduce egg
retention. After 2-h egg collection intervals at 25uC, eggs were
transferred to petri dishes containing fresh yeast paste and reared
at 25uC. Pupariation was scored in 2-h intervals. For the hsRNAi
experiments, larvae were reared on yeast until the late L2 stage, at
which w
1118 controls and hsDHR4-RNAi L2 larvae were heat
shocked for 35 min at 37.5uC. After a 4-h recovery, newly molted
L3 larvae were transferred to yeast paste supplemented with
0.05% bromophenol blue to monitor their gut clearing status
[71,72].
qPCR
All qPCR data shown here are based on 3–4 biological samples
each tested in triplicate. Whole larvae were collected in distilled
water and snap-frozen in liquid nitrogen, while dissected tissue
samples were prepared in ice-cold PBS, rinsed twice with fresh
PBS, transferred to TRIzol (Invitrogen), and snap-frozen in liquid
nitrogen. Total RNA of whole larvae was isolated following a
modified TRIzol protocol, where we substituted sodium acetate
with lithium chloride for RNA precipitation. Total RNA from
tissue samples was extracted using the RNAqueous-Micro Kit
(Ambion) following the manufacturer’s instruction. RNA samples
(0.5–2 mg/reaction) were reverse transcribed using ABI High
Capacity cDNA Synthesis kit, and the synthesized cDNA was used
for qPCR (StepOnePlus, Applied Biosystems) using PowerSYBR
Green PCR master mix (Applied Biosystems) with 5 ng of cDNA
template with a primer concentration of 200 nM. Samples were
normalized to rp49 based on the DDCT method. All primer
sequences can be found in Table S1.
Transgenic Constructs
To generate pUAST-DHR4 cDNA, a 6.3 kb fragment contain-
ing the full-length synthetic cDNA of DHR4 [35] was cut with Eco
RI and Xba I from Litmus 28 and cloned into pUAST digested with
the same enzymes. For the pUAST-DHR4-RNAi construct, the
same inverted repeat used in the hsDHR4-RNAi [35] was used to
clone the fragment into pUAST using Xba I for all restriction cuts.
Transgenic flies were generated by injecting DNA at a
concentration of 0.5 mg/ml along with 0.1 mg/ml helper plasmid
pD2–3 into embryos following standard procedures [73,74].
Immunostaining
Tissues were dissected from larvae in PBS, fixed in 4%
paraformaldehyde (EMS #15710) in PBST (PBS containing
0.3% Triton-X 100) for 20 min at room temperature (RT), and
washed in PBST. Tissues were then blocked for 2 h at RT or
overnight at 4uC in PBST/5% NGS. Primary antibodies were
incubated at 4uC overnight, while the secondary antibody was
either incubated overnight at 4uC or 4 h at RT. Nuclei were
stained with DAPI (1:5000). After several wash steps, tissues were
mounted in SlowFade Gold Antifade Reagent (Invitrogen). Images
were captured on a Nikon C1 plus confocal microscope. Anti-
DHR4 antibody was used at a dilution of 1:500, and anti-ERK
antibody was used at a dilution of 1:100 (Cell Signaling #4695).
Secondary antibodies (anti-rabbit Cy3) were used at a dilution of
1:200 (Rockland #611-104-122).
Ring Gland Microarrays
DHR4-RNAi and w
1118 populations were heat shocked as late
L2 larvae for 35 min at 37.5uC. To carefully stage larvae at the
L2/L3 molt, L3 larvae were discarded 4 h after the heat
treatment, and L3 larvae that molted in the following hour were
allowed to feed for either 4 h or 8 h before their ring glands were
dissected in ice-cold PBS. Ten ring glands were dissected and
washed twice in PBS before being transferred to ice-cold TRIzol
reagent (Invitrogen). The lysates were then vortexed for 5 s at RT,
flash frozen, and stored at 280uC. Total RNA was isolated by
Ambion RNAqueous-Micro Kit. Isolated RNA was quantified by
RiboGreen Quanti Kit (Invitrogen) and RNA integrity was
analyzed by Agilent Bioanalyzer Pico Chips. RNA linear
amplification was based on the MessageII RNA Amplification
kit (Ambion): First-strand cDNA synthesis was carried out by a T7-
(dT) primer and ArrayScript reverse transcriptase using 50 ng
RNA of each ring gland sample. Second-strand cDNA synthesis
was performed according to the provided protocol. Purified cDNA
was then fed into the IVT reactions. The amplified RNA (aRNA)
was column-purified and analyzed by Agilent Bioanalyzer Nano
chips. 1 mg of aRNA was used for double-stranded cDNA
synthesis (Invitrogen SuperScript One-Cycle cDNA Kit) and
1 mg of the purified cDNA was Cy3-labeled by Roche NimbleGen
one-color cDNA labeling kit. From this, 4 mg of Cy3-labeled
cDNA was hybridized on a Drosophila 126135K Array (Nimble-
Gen). Each condition was analyzed by three independent
biological samples. Chip hybridization and scanning was per-
formed by the Alberta Transplant Applied Genomics Center. Raw
data were normalized with the NimbleScan software (NimbleGen)
using the RMA algorithm [75], and data were analyzed with
Arraystar 4.0 (DNAstar) as well as Access (Microsoft).
Ecdysteroids Measurements
Larvae were collected in 1.5 ml tubes and stored at 280uC.
Samples were then homogenized in methanol and centrifuged at
maximum speed, after which the precipitates were re-extracted
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centrifuge. The dried extracts were thoroughly dissolved in EIA
buffer at 4uC overnight prior to the EIA assay. 20E EIA antiserum
(#482202), 20E AChE tracer (#482200), Precoated (Mouse Anti-
Rabbit IgG) EIA 96-Well Plates (#400007), and Ellman’s Reagent
(#400050) were all purchased from Cayman Chemical, and assays
were performed according to the manufacturer’s instructions.
Sterol rescue experiments. We used two types of media,
standard medium and instant food. For 20E-containing standard
medium, 33 mg of 20E (Steraloids Inc.) was dissolved in 100 ml of
6% ethanol, of which ,2 ml was added to 1 g of dry baker’s yeast
for a single plate. Control food contained 6% ethanol w/o 20E.
30,40 larvae were raised on each yeast plate in order to avoid
overpopulation. For the rescue experiment of Cyp6t3-RNAi larvae
with ecdysteroid precursors, we used an instant fly medium (‘‘4–
24,’’ Carolina Biological Supply Company, hereafter referred to as
C424), which is naturally low in cholesterol and other sterols [50].
Ecdysteroid precursors were dissolved in 100% ethanol, and added
to each vial with 1 g C424 powder. Ethanol was allowed to
evaporate completely before the medium was mixed vigorously
with 5 ml of distilled water. The final concentrations for the
precursors used were: cholesterol: 20 mg/ml and 7-dehydro-
cholesterol: 100 mg/ml, 5b-ketodiol: 200 mg/ml, E: 40 mg/ml,
20E: 200 mg/ml. 5b-ketodiol was a kind gift from Ryusuke Niwa;
all other sterols were purchased from Steraloids Inc.
In situ RNA Hybridization
DIG-labeled RNA probes were generated by in vitro transcrip-
tion following the manufacturer’s instructions (Roche DIG RNA
Labeling Mix, #11 277 073 910). L3 larvae were dissected in ice-
cold PBS and fixed in 4% paraformaldehyde for 20 min at RT.
After treatment with 1% H2O2, samples were stored in
hybridization buffer at 220uC. Tissues were pre-hybridized in
hybridization buffer for 3 h at 58uC and RNA probes were
denatured for 3 min at 80uC h. Probe hybridization was
performed for 18 h at 58uC, followed by extensive wash steps at
58uC. After cooling, tissues were blocked with PBTB buffer (2%
NGS and 1% BSA) for 1 h at RT before overnight incubation
with mouse Anti-Digoxin antibody (Jackson ImmunoResearch
Cat. # 200-062-156, 1:500 dilution) at 4uC. Tissues were then
incubated with streptavidin-HRP conjugates (Molecular Probes
#S991, 1:400 dilution) in PBTB for 1 h at RT, followed by six
wash steps (1 h each) in PBTB at RT. Before TSA amplification,
tissues were washed in PBTB. Tyramide reagents (PerkinElmer
TSA Plus Cyanine 3 Kit, Cat. #NEL744001KT) were diluted
1:1000 in 16 amplification buffer provided by the kit. TSA
reactions were performed for 40 min at RT and washed 6 times
for 1 h in PBS at RT. Tissues were mounted in the ProLong Gold
antifade reagent (Invitrogen, P36934) and analyzed by confocal
microscopy (Nikon AZ-C1 Confocal Microscope System).
Supporting Information
Figure S1 Schematic representation of DHR4 expression
profiles during Drosophila larval development. DHR4 is expressed
in the prothoracic gland (red) throughout larval development, but
fat body expression of DHR4 (brown) only occurs prior to molts
and during puparium formation. y-axis represents relative 20E
titers. This idealized ecdysone curve represents data from several
papers [5,76,77]. The tissue-specific expression of DHR4
represents data from this article and our previous report about
DHR4 [35].
(PDF)
Figure S2 qPCR analysis of Sgs-4 transcripts levels in larvae heat
treated in early hsDHR4-RNAi L3 larvae. Sgs-4 transcripts levels of
hsDHR4-RNAi (grey) animals with RNAi treatment in early L3
were analyzed by qPCR. Hours are relative to the L2/L3 molt. All
fold changes were normalized to 16-h time point in controls
(black). Error bars represent 95% confidence intervals.
(PDF)
Figure S3 Time course qPCR analysis of E74 transcripts levels
in larvae heat treated in late L2 or early L3. E74A (upper panels)
and E74B (bottom panels) transcripts levels were plotted as hours
relative to the L2/L3 molt, and all fold changes were calibrated to
either the control 0-h time point (left panels) or the 8-h time point
(right panels). Circles represent controls (w
1118) and squares stand
for hsDHR4-RNAi larvae. Left panels: L2 larvae received heat
shock ,4 h before the molt to L3. Right panels: L3 larvae were
heat shocked 4 h after the L2/L3 molt. Error bars represent 95%
confidence intervals.
(PDF)
Figure S4 Cyp6t3 transcripts are specifically enriched in the ring
gland. qPCR analysis of Cyp6t3 mRNA levels in ring gland (RG,
grey bar) versus whole body (WB, black bar) isolated at 4 h after
the molt. RNA from w
1118 ring glands and total larvae were
linearly amplified before qPCR analysis. Error bars represent 95%
confidence intervals.
(PDF)
Figure S5 Time course qPCR analysis in early w
1118 L3 larvae.
Brain-ring gland complexes were isolated from carefully staged
animals, and qPCR was carried out to measure relative mRNA
levels of selected cytochrome P450 genes in w
1118 at 0, 4, 8, and
12 h after the L2/L3 molt. All fold changes were normalized to
the 0-h time point. Error bars represent 95% confidence intervals.
(PDF)
Figure S6 Phenotypic characterization of Cyp6t3-RNAi line
#30896 (VDRC). (A) Time course of puparium formation in
phm22.Cyp6t3-RNAi (orange) and phm22 x w
1118 control lines
(black). Error bars reflect standard deviation, which are based on
three replicates. (B) 20E rescues large pupal phenotype. The
developmental delay shown in (A) results in larger phm22.Cyp6t3-
RNAi animals (3
rd pupa from left) while phm22 x w
1118 controls are
normal sized (left pupa). Supplementing media with 20E results in
normal-sized controls and phm22.Cyp6t3-RNAi animals. N=180
for each condition.
(PDF)
Figure S7 Whole-body ecdysteroid titers for Cyp6t3 RNAi
embryos and larvae. (A) Whole-body ecdysteroid titers for controls
(phm22.w
1118, grey) and phm22.Cyp6t3-RNAi animals (striped).
Left: embryos (in pg/100 embryos). Middle: L1 larvae (in pg/100
larvae). Right: L2 larvae (in pg/larva) at different time points as
indicated. Error bars indicate standard error. * p,0.01. In L2, the
ecdysone pulse occurs in the 6–12 h time window, while the 18–
24 h window lies outside the peak.
(PDF)
Figure S8 Sequence alignment of Drosophila melanogaster Cyp6t3
with related proteins from a variety of species. Cyp6t3 from
Drosophila melanogaster (Dm) was aligned with the most highly
conserved proteins from representatives of Diptera (Drosophila
pseudoobscura, Dpse; Aedes aegypti; Aa and Anopheles gambiae; Ag),
Lepidoptera (Bombyx mori; Bm), Coleoptera (Tribolium castaneum; Tc),
and Hymenoptera (Apis mellifera; Am), as well as the Dm protein
Phantom (a less closely related member of the Cyp306 family).
The sequences of Dm Cyp6t3, Dpse Cyp6t3, and Dm Phm were
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BLASTp search specific for each of the organisms indicated above,
and all the top hits along with Dm Phm and Dpse Cyp6t3 were
aligned using ClustalW2 (Gonnet weight Matrix, gap penalty
N=10, gap extension penalty N=0.2). BoxShade was used to
shade the resultant alignment. Dark shading indicates a residue
that shares identity with .60% of the aligned residues at that
position, while the light shading indicates .60% similarity.
(PDF)
Figure S9 Phylogenetic tree of Drosophila melanogaster Cyp6t3
with related proteins from a variety of species. The aligned
proteins were assembled into a phylogenetic tree using SeaView
[65]. To construct the tree, the parsimony algorithm was used and
bootstrapped with 1,000 replicates. Numbers indicate the support
values for each node.
(PDF)
Table S1 A list of all primers used for qPCR and in situ
hybridization.
(PDF)
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